Nitroreductase-Based "Turn-On" Fluorescent Probe for Bacterial Identification with Visible Features.
Buyue ZhangHuan ChenLei ShiRuirui GuoYan WangYehuan ZhengRuiyang BaiYuexing GaoBing LiuXiufeng ZhangPublished in: ACS sensors (2024)
Among pathogenic bacteria, Escherichia coli , Enterococcus faecium , Staphylococcus aureus , Klebsiella pneumoniae , Acinetobacter baumannii , and Pseudomonas aeruginosa were the six leading causes for the deaths associated with antibiotic resistance in 2019. Although new treatment options are urgently needed, the precise identification of the bacterial species remains pivotal for an accurate diagnosis and effective treatment. Clinically, mass spectrometry is used to distinguish these bacteria based on their protein mass pattern at the genus and species level. Herein, we report an alternative approach to identify these bacteria using the nitroreductase-based "turn-on" fluorescent probes ( ETH1-NO 2 and ETH2-NO 2 ), with potential visual indicators for the six individual bacteria species. The limits of detection (LODs) of the probes for NTRs are 0.562 ( ETH1-NO 2 ) and 0.153 μg/mL ( ETH2-NO 2 ), respectively. They respond effectively to both Gram-positive and Gram-negative bacteria, with the lowest LOD at 1.2 × 10 6 CFU/mL for E. coli . In particular, different bacteria show noticeable difference in the apparent color of ETH1-NO 2 samples, allowing possible identification of these bacteria visually. In addition, ETH1-NO 2 also has potential applications in bacterial fluorescence imaging. Thus, our study provides an alternative approach for bacteria identification and new reagents for bacteria imaging.
Keyphrases
- living cells
- fluorescent probe
- escherichia coli
- fluorescence imaging
- pseudomonas aeruginosa
- acinetobacter baumannii
- klebsiella pneumoniae
- multidrug resistant
- staphylococcus aureus
- mass spectrometry
- high resolution
- drug resistant
- biofilm formation
- small molecule
- photodynamic therapy
- gram negative
- single molecule
- magnetic resonance
- climate change
- binding protein
- label free
- sensitive detection
- combination therapy
- genetic diversity